Articles citing this paper
cfArticle2ecfc1291681887$funcTITLE@2ba2e1a2
Saeed Ghasemi A , Simin Sharifi C D , Soodabeh Davaran A C D , Hosein Danafar A , Davoud Asgari A C and Javid Shahbazi Mojarrad A B E
+ Author Affiliations
- Author Affiliations
A Department of Medicinal Chemistry, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz 51664, Iran.
B Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz 51664, Iran.
C Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz 51664, Iran.
D Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz 51664, Iran.
E Corresponding author. Email: jvshahbazi@yahoo.com
Australian Journal of Chemistry 66(6) 655-660 https://doi.org/10.1071/CH13031
Submitted: 19 January 2013 Accepted: 22 February 2013 Published: 25 March 2013
3 articles found in Crossref database.
FTase inhibitors and cancer: prospects for use in targeted therapies
Xia Ming-tao,
Yu Ling,
Yan Zhi-wei,
Wang You-de,
Zhang Li-ying,
Miao Guang-xin, Li Shuai
Medicinal Chemistry Research. 2024 33(1). p.21
6,7-Disubstituted-4-anilinoquinazoline: Design, Synthesis and Anticancer Activity as a Novel Series of Potent Anticancer Agents
Azmian Moghadam Fatemeh,
Evazalipour Mehdi,
Kefayati Hassan, Ghasemi Saeed
Pharmaceutical Sciences. 2020 27(2). p.209
Design, Synthesis and Biological Evaluation of Novel Piperazinone Derivatives as Cytotoxic Agents
Ghasemi Saeed,
Sharifi Simin, Shahbazi Mojarrad Javid
Advanced Pharmaceutical Bulletin. 2020 10(3). p.423